Эпштейна–Барр вирусная инфекция и ревматические заболевания
https://doi.org/10.14412/1996-7012-2026-1-7-12
Аннотация
Вирус Эпштейна–Барр – широко распространенный герпесвирус 4-го типа, которым инфицировано свыше 90% населения планеты. Его роль в развитии ревматических заболеваний активно изучается. В статье представлен анализ ключевых аспектов этой взаимосвязи, основанный на современных исследованиях.
Ключевые слова
При поддержке: Статья подготовлена в рамках научно-исследовательской работы, № государственного задания РК 125020301268-4
Об авторах
М. М. Баранова
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Россия
Марина Михайловна Баранова
Россия, 115522, Москва, Каширское шоссе, 34А
Н. В. Муравьева
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Россия
Россия, 115522, Москва, Каширское шоссе, 34А
Б. С. Белов
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Россия
Россия, 115522, Москва, Каширское шоссе, 34А
Литература
1. https://library.mededtech.ru/rest/documents/Inf_mononuclpdf23/
2. Robinson WH, Younis S, Love ZZ, et al. Epstein-Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol. 2024 Nov; 20(11):729-740. doi: 10.1038/s41584-024-01167-9.
3. Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol. 2021 Jan 7:11:587380. doi: 10.3389/fimmu.2020.587380.
4. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr Med Assoc J. 2008 Jan;10(1):8-12.
5. Jog NR, James JA. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus. Front Immunol. 2021 Feb 3: 11:623944. doi: 10.3389/fimmu.2020.623944.
6. Minamitani T, Yasui T, Ma Y, et al. Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A. Proc Natl Acad Sci U S A. 2015 Sep 15;112(37): 11612-7. doi: 10.1073/pnas.1514484112.
7. Wang H, Nicholas MW, Conway KL, et al. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol. 2006 Sep 1;177(5): 2793-802. doi: 10.4049/jimmunol.177.5.2793.
8. Croia C, Serafini B, Bombardieri M, et al. Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis. 2013 Sep 1;72(9):1559-68. doi: 10.1136/annrheumdis-2012-202352.
9. Takei M, Kitamura N, Nagasawa Y, et al. Are Viral Infections Key Inducers of Autoimmune Diseases? Focus on Epstein-Barr Virus. Viruses. 2022 Aug 27;14(9):1900. doi: 10.3390/v14091900.
10. Pender MP. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune Dis. 2012: 2012:189096. doi: 10.1155/2012/189096.
11. Draborg AH, Jacobsen S, Westergaard M, et al. Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients. Lupus Sci Med. 2014 Apr 1; 1(1):e000015. doi: 10.1136/lupus-2014-000015.
12. Takei M, Ishiwata T, Mitamura K, et al. Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis. Int Immunol. 2001 Apr; 13(4):559-65. doi: 10.1093/intimm/13.4.559.
13. Горячев ДВ, Егорова ОН, Балабанова РМ. Системная красная волчанка и вирусные инфекции. Научно-практическая ревматология. 2000;(3):45-54.
14. Arbuckle MR, Reichlin M, Harley JB, et al. Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus. Scand J Immunol. 1999 Nov; 50(5):447-55. doi: 10.1046/j.1365-3083. 1999.00640.x.
15. James JA, Harley JB, Scofield RH. Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol. 2006 Sep; 18(5):462-7. doi: 10.1097/01.bor.0000240355.37927.94.
16. Poole BD, Scofield RH, Harley JB, et al. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006 Feb;39(1):63-70. doi: 10.1080/08916930500484849.
17. McClain MT, Heinlen LD, Dennis GJ, et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005 Jan;11(1):85-9. doi: 10.1038/nm1167.
18. Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol. 1993 May;23(5):1146-52. doi: 10.1002/eji.1830230525.
19. Sundar K, Jacques S, Gottlieb P, et al. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and antiSm antibodies. J Autoimmun. 2004 Sep;23(2): 127-40. doi: 10.1016/j.jaut.2004.06.001.
20. Yadav P, Tran H, Ebegbe R, et al. Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One. 2011 Jan 4;6(1):e14488. doi: 10.1371/journal.pone.0014488.
21. Csorba K, Schirmbeck LA, Tuncer E, et al. Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site. Front Immunol. 2019 Nov 7:10: 2619. doi: 10.3389/fimmu.2019.02619.
22. Incaprera M, Rindi L, Bazzichi A, et al. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin Exp Rheumatol. 1998 May-Jun;16(3): 289-94.
23. Baboonian C, Venables PJ, Williams DG, et al. Cross reaction of antibodies to a glycine/alanine repeat sequence of EpsteinBarr virus nuclear antigen-1 with collagen, cytokeratin, and actin. Ann Rheum Dis. 1991 Nov;50(11):772-5. doi: 10.1136/ard.50.11.772.
24. Davies JM, Mackay IR, Rowley MJ. Rheumatoid arthritis sera react with a phagedisplayed peptide selected by a monoclonal antibody to type II collagen that has homology to EBNA-1. Autoimmunity. 1999;30(1): 53-9. doi: 10.3109/08916939908994760.
25. Trier NH, Holm BE, Heiden J, et al. Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis. Sci Rep. 2018 Feb 27;8(1):3684. doi: 10.1038/s41598-018-22058-6.
26. Illescas-Montes R, Corona-Castro CC, Melguizo-Rodriguez L, et al. Infectious processes and systemic lupus erythematosus. Immunology. 2019 Nov;158(3):153-160. doi: 10.1111/imm.13103.
27. Münz C, Lünemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol. 2009 Apr;9(4):246-58. doi: 10.1038/nri2527.
28. Martin HJ, Lee JM, Walls D, et al. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus. J Virol. 2007 Sep;81(18):9748-58. doi: 10.1128/JVI.01122-07.
29. Ning S. Innate immune modulation in EBV infection. Herpesviridae. 2011 Jan 5; 2(1):1. doi: 10.1186/2042-4280-2-1.
30. Valente R.M., Ehlers E., Xu D., Ahmad H., Steadman A., Blasnitz L. et al. Toll-Like receptor 7 stimulates the expression of Epstein–Barr virus latent membrane protein 1. PLoS One. 2012;7(8):e43317. doi: 10.1371/journal.pone.0043317.
31. Li ZX, Zeng S, Wu HX, Zhou Y. The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis. Clin Exp Med. 2019 Feb;19(1):23-36. doi: 10.1007/s10238-018-0535-0.
32. Jog NR, Young KA, Munroe ME, et al. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann Rheum Dis. 2019 Sep;78(9):1235-1241. doi: 10.1136/annrheumdis-2019-215361.
33. Harley JB, James JA. Epstein-Barr virus infection induces lupus autoimmunity. Bull NYU Hosp Jt Dis. 2006;64(1-2):45-50.
34. Moon UY, Park SJ, Oh ST, et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther. 2004;6(4):R295-302. doi: 10.1186/ar1181.
35. Balandraud N, Meynard JB, Auger I, et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum. 2003 May;48(5):1223-8. doi: 10.1002/art.10933.
36. Takeda T, Mizugaki Y, Matsubara L, et al. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2000 Jun;43(6):1218-25. doi: 10.1002/1529-0131(200006)43:6<1218:AID-ANR4>3.0.CO;2-2.
37. Blaschke S, Schwarz G, Moneke D, et al. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J Rheumatol. 2000 Apr; 27(4):866-73.
38. Fechtner S, Berens H, Bemis E, et al. Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles. Arthritis Rheumatol. 2022 Apr; 74(4):597-603. doi: 10.1002/art.41994.
39. Banko A, Miljanovic D, Lazarevic I, et al. New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis. Viruses. 2022 Jan 10; 14(1):115. doi: 10.3390/v14010115.
40. Whittingham S, McNeilage LJ, Mackay IR. Epstein-Barr virus as an etiological agent in primary Sjögren's syndrome. Med Hypotheses. 1987 Apr;22(4):373-86. doi: 10.1016/0306-9877(87)90033-8.
41. Tsubota K, Fujishima H, Toda I, et al. Increased levels of Epstein-Barr virus DNA in lacrimal glands of Sjögren's syndrome patients. Acta Ophthalmol Scand. 1995 Oct; 73(5):425-30. doi: 10.1111/j.1600-0420.1995.tb00302.x.
42. Fox RI, Pearson G, Vaughan JH. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjögren's syndrome. J Immunol. 1986 Nov 15;137(10):3162-8.
43. Pasoto SG, Natalino RR, Chakkour HP, et al. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement? Rheumatol Int. 2013 May;33(5):1149-57. doi: 10.1007/s00296-012-2504-3.
44. Croia C, Astorri E, Murray-Brown W, et al. Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjö-gren's syndrome. Arthritis Rheumatol. 2014 Sep;66(9):2545-57. doi: 10.1002/art.38726.
45. Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. EBV and systemic lupus erythematosus: a new perspective. J Immunol. 2005 Jun 1;174(11):6599-607. doi: 10.4049/jimmunol.174.11.6599.
46. Chen CJ, Lin KH, Lin SC, et al. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol. 2005 Jan; 32(1):44-7.
47. Gao S, Yu Z, Ma X, et al. Childhood-onset systemic lupus erythematosus in China, 2016-21: a nationwide study. Lancet Child Adolesc Health. 2024 Oct;8(10):762-772. doi: 10.1016/S2352-4642(24)00172-X.
48. Nakamura J, Yanagida M, Saito K, et al. Epstein-Barr virus encephalitis in a patient with rheumatoid arthritis. Mod Rheumatol Case Rep. 2022 Jun 24;6(2):160-162. doi: 10.1093/mrcr/rxab045.
49. Yamashita H, Shimizu A, Tsuchiya H, et al. Chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis exacerbation in a patient with systemic lupus erythematosus. Lupus. 2014 Jul;23(8):833-6. doi: 10.1177/0961203314527367.
50. Haramura T, Haraguchi M, Irie J, et al. Case of plasmablastic lymphoma of the sigmoid colon and literature review. World J Gastroenterol. 2015 Jun 28;21(24):7598-603. doi: 10.3748/wjg.v21.i24.7598.
51. Егорова ОН, Балабанова РМ, Сажина ЕГ. Системная красная волчанка и оппортунистические инфекции: распространенность, клинические особенности. Современная ревматология. 2008;2(4):27-33. doi: 10.14412/1996-7012-2008-503.
52. Tiwari V, Bergman MJ. Viral Arthritis. In: StatPearls. Treasure Island: StatPearls Publishing; 2025.
53. Kim TH, Lee JH, Kim YC, Lee SE. Hydroa vacciniforme-like lymphoma misdiagnosed as cutaneous lupus erythematosus. J Cutan Pathol. 2015 Mar;42(3):229-231. doi: 10.1111/cup.12425.
54. Plaza JA, Sangueza M. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma. Am J Dermatopathol. 2015 Jan; 37(1):20-5. doi: 10.1097/DAD.0000000000000158.
55. Бзарова Т, Алексеева Е, Акулова С. Случай Эпштейн-Барр вирусной инфекции, протекавшей под маской системного варианта ювенильного ревматоидного артрита. Вопросы современной педиатрии. 2007;6(3):101-106.
Рецензия
Для цитирования:
Баранова ММ, Муравьева НВ, Белов БС. Эпштейна–Барр вирусная инфекция и ревматические заболевания. Современная ревматология. 2026;20(1):7-12. https://doi.org/10.14412/1996-7012-2026-1-7-12
For citation:
Baranova MM, Muravyeva NV, Belov BS. Epstein–Barr virus infection and rheumatic diseases. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2026;20(1):7-12. (In Russ.) https://doi.org/10.14412/1996-7012-2026-1-7-12
Просмотров:
601
JATS XML
Послать статью по эл. почте 
